Grace Therapeutics, Inc. (GRCE)

Cash & Short-Term Investments

$13.76M

Quarterly · Period ending: · USD

GRCE logo

GRCE Cash & Short-Term Investments

Latest reported$16.98M
GRCE FY Cash & Short-Term Investments ($2.34M → $16.98M)
High-resolution chart · PNG

GRCE cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Grace Therapeutics, Inc. Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
16,977,000
22,133,000
23,005,000
27,890,000
43,661,000
76,293,116
20,129,308
25,759,000
6,367,458
9,779,961
7,726,310
14,691,768
21,301,602
4,673,792
7,173,967
2,893,588
404,965
2,340,279
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.